Predeposit autologous blood transfusion in patients with colorectal cancer: A feasibility study
Article first published online: 8 DEC 2005
Copyright © 1992 British Journal of Surgery Society Ltd.
British Journal of Surgery
Volume 79, Issue 4, pages 355–357, April 1992
How to Cite
Harrison, S., Steele, R. J. C., Johnston, A. K., Jones, J. A., Morris, D. L. and Hardcastle, J. D. (1992), Predeposit autologous blood transfusion in patients with colorectal cancer: A feasibility study. Br J Surg, 79: 355–357. doi: 10.1002/bjs.1800790426
- Issue published online: 8 DEC 2005
- Article first published online: 8 DEC 2005
- Manuscript Accepted: 18 NOV 1991
- Medical Research Council. Grant Number: G8724076SPG
Over a 2-year period, a predeposit autologous blood transfusion service was provided for all patients undergoing elective surgery for left-sided colonic or rectal cancer in one hospital. Of 129 such patients, 28 were suitable for autologous donation. Eight of these received autologous blood only, 13 required no transfusion, and seven needed additional homologous blood. Thus, although predeposit autologous transfusion for patients with colorectal cancer is possible, only a very small proportion are likely to derive any benefit which it might confer.